UNICA IRIS Institutional Research Information System

MASSA, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 147.728
NA - Nord America 14.481
AS - Asia 5.632
SA - Sud America 848
Continente sconosciuto - Info sul continente non disponibili 382
AF - Africa 157
OC - Oceania 15
AN - Antartide 1
Totale 169.244
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 142.569
US - Stati Uniti d'America 14.158
SG - Singapore 2.091
CN - Cina 2.078
NL - Olanda 1.909
UA - Ucraina 968
SE - Svezia 663
BR - Brasile 640
VN - Vietnam 500
FI - Finlandia 394
GB - Regno Unito 339
DE - Germania 331
FR - Francia 269
HK - Hong Kong 186
CA - Canada 167
KR - Corea 145
IN - India 120
BD - Bangladesh 88
AR - Argentina 74
MX - Messico 55
TR - Turchia 55
RU - Federazione Russa 54
ZA - Sudafrica 52
IQ - Iraq 49
AT - Austria 42
JP - Giappone 37
PK - Pakistan 35
PH - Filippine 33
IR - Iran 30
ES - Italia 29
CO - Colombia 27
EC - Ecuador 27
ID - Indonesia 27
PL - Polonia 26
BE - Belgio 24
SA - Arabia Saudita 23
CL - Cile 22
VE - Venezuela 20
IE - Irlanda 19
JM - Giamaica 18
KE - Kenya 18
UZ - Uzbekistan 18
MA - Marocco 17
CR - Costa Rica 16
CZ - Repubblica Ceca 15
PY - Paraguay 15
AE - Emirati Arabi Uniti 14
TN - Tunisia 13
AU - Australia 12
MY - Malesia 12
TT - Trinidad e Tobago 12
LT - Lituania 11
TW - Taiwan 11
EG - Egitto 10
NP - Nepal 10
PE - Perù 10
BO - Bolivia 8
CH - Svizzera 8
ET - Etiopia 8
HN - Honduras 8
IL - Israele 8
JO - Giordania 8
NI - Nicaragua 8
RO - Romania 8
SV - El Salvador 8
EU - Europa 7
KZ - Kazakistan 7
NG - Nigeria 7
SC - Seychelles 7
EE - Estonia 6
GT - Guatemala 6
OM - Oman 6
AZ - Azerbaigian 5
CW - ???statistics.table.value.countryCode.CW??? 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
LV - Lettonia 5
PR - Porto Rico 5
AL - Albania 4
AM - Armenia 4
BB - Barbados 4
GR - Grecia 4
LB - Libano 4
PT - Portogallo 4
TH - Thailandia 4
UY - Uruguay 4
BG - Bulgaria 3
BH - Bahrain 3
BS - Bahamas 3
CG - Congo 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
MK - Macedonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
Totale 168.829
Salva come PNG Salva come JPEG
Città #
Cagliari 137.435
Uta 4.291
Amsterdam 1.881
Ashburn 1.699
Fairfield 1.171
Singapore 1.044
Woodbridge 1.023
San Jose 879
Houston 837
Chandler 678
Dallas 654
Boardman 567
Jacksonville 559
Seattle 503
Wilmington 483
Ann Arbor 481
Nyköping 466
Cambridge 413
Beijing 360
Dearborn 258
Council Bluffs 246
Los Angeles 235
Helsinki 226
Santa Clara 208
Ho Chi Minh City 189
New York 187
Nanjing 174
Hong Kong 165
Hefei 158
Boston 153
Lauterbourg 145
The Dalles 140
Seoul 132
Shanghai 118
Buffalo 109
Guangzhou 96
San Diego 94
Hanoi 92
Milan 87
São Paulo 73
Toronto 65
Munich 59
Nanchang 57
Chicago 54
Rome 49
Shenyang 49
Hangzhou 45
London 45
Changsha 43
Hebei 42
Redondo Beach 40
Tianjin 40
Phoenix 38
Redwood City 36
Jiaxing 34
Orem 34
Frankfurt am Main 33
Jinan 32
Verona 32
Atlanta 29
Columbus 29
Nuremberg 29
Tokyo 29
Norwalk 28
Rio de Janeiro 28
Orange 26
Brooklyn 25
Da Nang 24
San Francisco 24
Naples 23
Denver 22
Pune 22
Warsaw 22
Brussels 21
Chennai 21
Montreal 21
North Bergen 21
Sassari 21
Baghdad 20
Johannesburg 20
Vienna 20
Auburn Hills 19
Zhengzhou 19
Belo Horizonte 18
Dublin 18
Haiphong 18
Kunming 18
Mountain View 18
Turku 18
Washington 18
Dhaka 16
Manchester 16
Mexico City 16
Philadelphia 16
Tashkent 16
Wuhan 16
Ankara 14
Shenzhen 14
Stockholm 14
Biên Hòa 13
Totale 160.376
Salva come PNG Salva come JPEG
Nome #
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.912
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 3.012
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.982
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.848
Molecular-biology-driven treatment for metastatic colorectal cancer 2.795
Sense of coherence and physical health-related quality of life in Italian chronic patients: The mediating role of the mental component 2.757
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.663
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship? 2.648
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.594
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.495
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.387
VITAMIN C SUPPLEMENTATION IN CANCER CACHEXIA AND RELATED-OXIDATIVE STRESS 2.267
Health related quality of life in patients with onco-hematological diseases 2.262
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.217
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.910
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial 1.866
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial 1.806
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.803
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 1.765
The nutritional risk in oncology: a study of 1,453 cancer outpatients 1.746
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.732
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.728
The Quality of Life of People with Solid Cancer is Less Worse than Other Diseases with better Prognosis, Except in the Presence of Depression 1.712
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.710
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.687
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.686
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 1.667
Immunotherapy and Cancer: The Multi-Omics Perspective 1.648
Weight loss in cancer patients: a plea for a better awareness of the issue 1.609
Case-control Phase ii clinical trial to assess efficacy and safety, of the same antineoplastic treatment(s) in elderly "fit" compared to adult patients with cancer at different sites 1.567
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.532
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause 1.524
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.497
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia = Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: Final analysis of GIDEON study in Italy 1.494
null 1.489
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.339
null 1.306
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.300
Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens 1.232
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.213
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.195
Moderate exercise improves cognitive function in healthy elderly people: results of a randomized controlled trial 1.174
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.165
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma 1.117
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 1.088
PAX8 Positivity, Abnormal p53 Expression, and p16 Negativity in a Primary Endometrial Squamous Cell Carcinoma: A Case Report and Review of the Literature 1.070
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study 1.039
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 1.010
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 1.008
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 983
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer 983
An attempt to correlate a "Multidimensional Geriatric Assessment" (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study 961
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 961
null 944
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 930
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer 918
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 860
ALCOL E TUMORE ALLA MAMMELLA 843
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 841
Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients 810
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 808
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 803
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 802
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 799
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 797
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 791
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 782
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 780
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 777
null 768
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 765
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 748
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 747
Early epirubicin (EPI)-induced myocardial dysfunction revealed by serial tissue doppler imaging (TDI): Correlation with inflammatory and oxidative stress markers 742
Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy 736
Risk factors for sentinel lymph node involvement in patients with apparent early-stage endometrial cancer: a retrospective single-center study 720
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 718
HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review 711
null 709
null 694
null 688
null 681
Low adherence to therapy and co-morbid depressive episodes are independent determinants of early death in people with cancer 678
p16 Block Type Overexpression, p53 Wild Type Reactivity, and Cervical Involvement do not Always Exclude the Diagnosis of Primary Endometrial Squamous Cell Carcinoma (PESCC) 656
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 651
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 649
Adherence to treatment in patients with solid and hematological cancers. Could spiritual and psychological support facilitate optimal adherence? 646
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 644
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 637
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 632
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 629
Managing cancer-related anorexia/cachexia 628
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 621
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 618
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 616
Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer 614
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 609
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 607
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 603
Assessment of impact on quality of life (QOL) of endoscopic laser ablation (LA) as palliative treatment of endobronchial, non-resectable or recurrent lung cancer 599
Totale 128.210
Salva come PNG Salva come JPEG
Categoria #
all - tutte 249.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 249.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.724 0 0 0 0 659 504 320 348 583 492 814 1.004
2022/202312.087 956 1.396 1.196 1.047 1.060 1.211 577 1.429 832 772 1.019 592
2023/202415.869 1.357 542 511 1.008 1.574 3.191 1.579 1.023 781 1.356 1.512 1.435
2024/202533.508 7.200 9.237 4.138 3.944 2.037 3.756 1.424 182 446 310 384 450
2025/202612.515 592 558 1.260 878 773 699 1.857 650 2.687 1.484 733 344
2026/20273.840 114 865 1.229 1.541 91 0 0 0 0 0 0 0
Totale 169.244